Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated Computational Design-Synthesis Platform for Peptide Drug Discovery
Company Announces Core Leadership Team, Led by CEO, Kerry L. Blanchard, MD, PhD November 30, 2023 05:00 PM Pacific Standard Time SHANGHAI & BOSTON–(BUSINESS WIRE)–Perpetual Medicines today announced it has closed an $8 million seed…